{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T17:56:26Z","timestamp":1770486986865,"version":"3.49.0"},"reference-count":56,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2016,10,18]]},"published-print":{"date-parts":[[2018,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Hodgkin's lymphoma survivors who were treated with infradiaphragmatic radiotherapy or procarbazine-containing chemotherapy have a fivefold increased risk of developing colorectal cancer (CRC). This study aims to provide insight into the development of therapy-related CRC (t-CRC) by evaluating histopathological and molecular characteristics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>\n                      54 t-CRCs diagnosed in a Hodgkin's lymphoma survivor cohort were analysed for mismatch repair (MMR) proteins by immunohistochemistry, microsatellite instability (MSI) and\n                      <jats:italic>KRAS<\/jats:italic>\n                      \/\n                      <jats:italic>BRAF<\/jats:italic>\n                      mutations. MSI t-CRCs were evaluated for promoter methylation and mutations in MMR genes. Pathogenicity of MMR gene mutations was evaluated by\n                      <jats:italic>in silico<\/jats:italic>\n                      predictions and functional analyses. Frequencies were compared with a general population cohort of CRC (n=1111).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:italic>KRAS<\/jats:italic>\n                      and\n                      <jats:italic>BRAF<\/jats:italic>\n                      mutations were present in 41% and 15% t-CRCs, respectively. Compared with CRCs in the general population, t-CRCs had a higher MSI frequency (24% vs 11%, p=0.003) and more frequent loss of MSH2\/MSH6 staining (13% vs 1%, p&lt;0.001). Loss of MLH1\/PMS2 staining and\n                      <jats:italic>MLH1<\/jats:italic>\n                      promoter methylation were equally common in t-CRCs and the general population. In MSI CRCs without\n                      <jats:italic>MLH1<\/jats:italic>\n                      promoter methylation, double somatic MMR gene mutations (or loss of heterozygosity as second hit) were detected in 7\/10 (70%) t-CRCs and 8\/36 (22%) CRCs in the general population (p=0.008). These MMR gene mutations in t-CRCs were classified as pathogenic. MSI t-CRC cases could not be ascribed to Lynch syndrome.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We have demonstrated a higher frequency of MSI among t-CRCs, which results from somatic MMR gene mutations. This suggests a novel association of somatic MMR gene mutations with prior anticancer treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/gutjnl-2016-312608","type":"journal-article","created":{"date-parts":[[2016,11,9]],"date-time":"2016-11-09T07:25:33Z","timestamp":1478676333000},"page":"447-455","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":30,"title":["Double somatic mutations in mismatch repair genes are frequent in colorectal cancer after Hodgkin's lymphoma treatment"],"prefix":"10.1136","volume":"67","author":[{"given":"Lisanne S","family":"Rigter","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Netherlands Cancer Institute, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petur","family":"Snaebjornsson","sequence":"additional","affiliation":[{"name":"Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efraim H","family":"Rosenberg","sequence":"additional","affiliation":[{"name":"Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peggy N","family":"Atmodimedjo","sequence":"additional","affiliation":[{"name":"Department of Pathology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berthe M","family":"Aleman","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jelle","family":"ten Hoeve","sequence":"additional","affiliation":[{"name":"Division of Computational Biology, Netherlands Cancer Institute, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willemina R","family":"Geurts-Giele","sequence":"additional","affiliation":[{"name":"Department of Pathology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"PALGA group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas W","family":"van Ravesteyn","sequence":"additional","affiliation":[{"name":"Division of Biological Stress Response, Netherlands Cancer Institute, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Hoeksel","sequence":"additional","affiliation":[{"name":"Division of Biological Stress Response, Netherlands Cancer Institute, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerrit A","family":"Meijer","sequence":"additional","affiliation":[{"name":"Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hein","family":"te Riele","sequence":"additional","affiliation":[{"name":"Division of Biological Stress Response, Netherlands Cancer Institute, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flora E","family":"van Leeuwen","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Winand N","family":"Dinjens","sequence":"additional","affiliation":[{"name":"Department of Pathology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monique E","family":"van Leerdam","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Netherlands Cancer Institute, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2016,11,8]]},"reference":[{"key":"2025112109042332000_67.3.447.1","unstructured":"National Cancer Institute SEER Cancer Statistics Review, 1975\u20132007, 2010."},{"key":"2025112109042332000_67.3.447.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcsup.2014.05.001"},{"key":"2025112109042332000_67.3.447.3","unstructured":"Eggermond van AM , Schaapveld, M , Janus, C.P . Long-term risk of colorectal cancer in patients treated for Hodgkin's lymphoma. Gastroenterology Abstract 2013."},{"key":"2025112109042332000_67.3.447.4","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dji278"},{"key":"2025112109042332000_67.3.447.5","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-156-11-201206050-00002"},{"key":"2025112109042332000_67.3.447.6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.37.8760"},{"key":"2025112109042332000_67.3.447.7","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23601"},{"key":"2025112109042332000_67.3.447.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1505949"},{"key":"2025112109042332000_67.3.447.9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.0936"},{"key":"2025112109042332000_67.3.447.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2011.05.069"},{"key":"2025112109042332000_67.3.447.11","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-014-3706-6"},{"key":"2025112109042332000_67.3.447.12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.07.131"},{"key":"2025112109042332000_67.3.447.13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-10-532184"},{"key":"2025112109042332000_67.3.447.14","first-page":"19","article-title":"Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive","volume":"29","author":"Casparie","year":"2007","journal-title":"Cell Oncol"},{"key":"2025112109042332000_67.3.447.15","doi-asserted-by":"crossref","first-page":"e86657","DOI":"10.1371\/journal.pone.0086657","article-title":"Comparison of CpG island methylator phenotype (CIMP) frequency in colon cancer using different probe- and gene-specific scoring alternatives on recommended multi-gene panels","volume":"9","author":"Berg","year":"2014","journal-title":"PLoS ONE"},{"key":"2025112109042332000_67.3.447.16","doi-asserted-by":"publisher","DOI":"10.2353\/jmoldx.2007.060170"},{"key":"2025112109042332000_67.3.447.17","doi-asserted-by":"publisher","DOI":"10.1002\/path.4419"},{"key":"2025112109042332000_67.3.447.18","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkq603"},{"key":"2025112109042332000_67.3.447.19","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jmoldx.2016.06.002","article-title":"Diagnostic detection of allelic losses and imbalances by next-generation sequencing: 1p\/19q co-deletion analysis of gliomas","volume":"18","author":"Dubbink","year":"2016","journal-title":"J Mol Diagn"},{"key":"2025112109042332000_67.3.447.20","doi-asserted-by":"publisher","DOI":"10.1002\/humu.20880"},{"key":"2025112109042332000_67.3.447.21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/ng.2854","article-title":"Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database","volume":"46","author":"Thompson","year":"2014","journal-title":"Nat Genet"},{"key":"2025112109042332000_67.3.447.22","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2005.033878"},{"key":"2025112109042332000_67.3.447.23","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2009.86"},{"key":"2025112109042332000_67.3.447.24","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth0810-575"},{"key":"2025112109042332000_67.3.447.25","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.2890"},{"key":"2025112109042332000_67.3.447.26","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth0410-248"},{"key":"2025112109042332000_67.3.447.27","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1520813113"},{"key":"2025112109042332000_67.3.447.28","doi-asserted-by":"publisher","DOI":"10.1002\/path.3963"},{"key":"2025112109042332000_67.3.447.29","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.08.041"},{"key":"2025112109042332000_67.3.447.30","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.12.002"},{"key":"2025112109042332000_67.3.447.31","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-012-9568-9"},{"key":"2025112109042332000_67.3.447.32","doi-asserted-by":"publisher","DOI":"10.1038\/nature11252"},{"key":"2025112109042332000_67.3.447.33","doi-asserted-by":"publisher","DOI":"10.1016\/S1383-5742(00)00016-8"},{"key":"2025112109042332000_67.3.447.34","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1053\/j.gastro.2014.07.052","article-title":"Temozolomide increases the number of mismatch repair-deficient intestinal crypts and accelerates tumorigenesis in a mouse model of lynch syndrome","volume":"147","author":"Wojciechowicz","year":"2014","journal-title":"Gastroenterology"},{"key":"2025112109042332000_67.3.447.35","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2008.426"},{"key":"2025112109042332000_67.3.447.36","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.0959-9673.2006.00464.x","article-title":"Accelerated growth of intestinal tumours after radiation exposure in Mlh1-knockout mice: evaluation of the late effect of radiation on a mouse model of HNPCC","volume":"87","author":"Tokairin","year":"2006","journal-title":"Int J Exp Pathol"},{"key":"2025112109042332000_67.3.447.37","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/cas.12591","article-title":"Ionizing radiation, inflammation, and their interactions in colon carcinogenesis in Mlh1-deficient mice","volume":"106","author":"Morioka","year":"2015","journal-title":"Cancer Sci"},{"key":"2025112109042332000_67.3.447.38","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000100522","article-title":"Mild inflammation accelerates colon carcinogenesis in Mlh1-deficient mice","volume":"71","author":"Taniguchi","year":"2006","journal-title":"Oncology"},{"key":"2025112109042332000_67.3.447.39","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgq174"},{"key":"2025112109042332000_67.3.447.40","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200319757"},{"key":"2025112109042332000_67.3.447.41","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3185"},{"key":"2025112109042332000_67.3.447.42","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-3012"},{"key":"2025112109042332000_67.3.447.43","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.26083"},{"key":"2025112109042332000_67.3.447.44","doi-asserted-by":"publisher","DOI":"10.1126\/science.1239947"},{"key":"2025112109042332000_67.3.447.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2009.10.009"},{"key":"2025112109042332000_67.3.447.46","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403187"},{"key":"2025112109042332000_67.3.447.47","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-11-3343"},{"key":"2025112109042332000_67.3.447.48","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404381"},{"key":"2025112109042332000_67.3.447.49","first-page":"3012","article-title":"An intron splice acceptor polymorphism in hMSH2 and risk of leukemia after treatment with chemotherapeutic alkylating agents","volume":"9","author":"Worrillow","year":"2003","journal-title":"Clin Cancer Res"},{"key":"2025112109042332000_67.3.447.50","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1182\/blood.V88.11.4296.bloodjournal88114296","article-title":"Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype","volume":"88","author":"Ben-Yehuda","year":"1996","journal-title":"Blood"},{"key":"2025112109042332000_67.3.447.51","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S1568-7864(03)00020-X","article-title":"Drug treatment in the development of mismatch repair defective acute leukemia and myelodysplastic syndrome","volume":"2","author":"Casorelli","year":"2003","journal-title":"DNA Repair (Amst)"},{"key":"2025112109042332000_67.3.447.52","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02920.x"},{"key":"2025112109042332000_67.3.447.53","doi-asserted-by":"publisher","DOI":"10.1038\/sj\/leu\/2401466"},{"key":"2025112109042332000_67.3.447.54","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1182\/blood.V94.2.733","article-title":"Microsatellite instability and p53 mutations are associated with abnormal expression of the MSH2 gene in adult acute leukemia","volume":"94","author":"Zhu","year":"1999","journal-title":"Blood"},{"key":"2025112109042332000_67.3.447.55","first-page":"1027","article-title":"Molecular changes in second primary lung and breast cancers after therapy for Hodgkin's disease","volume":"9","author":"Behrens","year":"2000","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2025112109042332000_67.3.447.56","doi-asserted-by":"crossref","first-page":"e0117070","DOI":"10.1371\/journal.pone.0117070","article-title":"Genetic features of metachronous esophageal cancer developed in Hodgkin's lymphoma or breast cancer long-term survivors: an exploratory study","volume":"10","author":"Boldrin","year":"2015","journal-title":"PLoS ONE"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2016-312608","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T17:04:33Z","timestamp":1763744673000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2016-312608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,8]]},"references-count":56,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,2,8]]},"published-print":{"date-parts":[[2018,3]]}},"alternative-id":["10.1136\/gutjnl-2016-312608"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2016-312608","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,8]]}}}